Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
US Department of Justice
Farmers Insurance
Moodys
Merck
Queensland Health
Colorcon
Teva
Baxter

Generated: February 16, 2019

DrugPatentWatch Database Preview

Sodium nitroprusside - Generic Drug Details

« Back to Dashboard

What are the generic sources for sodium nitroprusside and what is the scope of sodium nitroprusside patent protection?

Sodium nitroprusside is the generic ingredient in four branded drugs marketed by Roche, Abbott, Abbvie, Hospira, Abraxis Pharm, Akorn, Amneal Pharms Co, Amphastar Pharms Inc, Baxter Hlthcare, Cipla, Medicure, Micro Labs, Mylan Labs Ltd, Namigen Llc, Nexus Pharms, Renaissance Ssa Llc, Somerset Theraps Llc, Sun Pharm Inds Ltd, Teva Parenteral, and Exela Pharma Scs Llc, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred and seventy-two drug master file entries for sodium nitroprusside. Twelve suppliers are listed for this compound.

Summary for sodium nitroprusside
Pharmacology for sodium nitroprusside
Drug ClassVasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for sodium nitroprusside

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Namigen Llc SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 207426-001 Dec 8, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abraxis Pharm SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 070031-001 Jan 17, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbott NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 071555-001 Nov 16, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cipla SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 210855-001 Jul 16, 2018 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Labs Ltd SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 210763-001 Apr 17, 2018 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
QuintilesIMS
McKesson
Boehringer Ingelheim
Fish and Richardson
Medtronic
Harvard Business School
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.